StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) income statement

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$7.31+0.37 (+5.33%)

Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –

OptimizeRx Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
73.2%
Operating margin
11.1%
Net margin
4.7%
Return on equity, FY2025
4.2%

Financial strength

Current ratio
5.58
Debt to equity
0.15
Debt to assets
11.6%
Cash to current liabilities
248.1%

Valuation

P/E ratio
30.5
Price to sales
1.40
Price to book
1.05
Dividend yield
–

See a number that looks wrong?